Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils

British Journal of Pharmacology

Volumn 116, Issue 7, 1995, Pages 2903-2908

  Armstrong, Roma A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

chemotaxis; cyclic AMP; Neutrophils; PGE analogues

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; BUTAPROST; CICAPROST; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; ROLIPRAM; SUPEROXIDE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SECOND MESSENGER;

ADENYLATE CYCLASE; ANALYSIS OF VARIANCE; CHEMOTAXIS, LEUKOCYTE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; ENZYME INHIBITORS; EPOPROSTENOL; HUMAN; IN VITRO; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PROSTAGLANDINS, SYNTHETIC; RECEPTORS, PROSTAGLANDIN E; SECOND MESSENGER SYSTEMS; SUPEROXIDES; SUPPORT, NON-U.S. GOV'T;

EID: 0028809831     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1995.tb15943.x     Document Type: Article

References (20)

1. Comparison of the prostaglandin E (EP) receptor of human neutrophils and HL‐60 cells differentiated with DMSO.
2. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
3. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes.
4. Characterization of prostanoid relaxant/ inhibitory receptors using a highly selective agonist, TR 4979.
5. A selective inhibitor of cyclic AMP‐dependent protein kinase, N‐[2‐bromocinnamyl(amino)ethyl]‐5‐isoquinolinesulfonamide (H‐89), inhibits phosphatidylcholine biosynthesis in HeLa cells.
6. Inhibition of adenylate cyclase in human blood platelets by 9‐substituted adenine derivatives.
7. 2.
8. Characterisation of the receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea‐pig ileum
9. Preparations of Rp‐cyclic adenosine 3′,5′‐phosphorothio‐nate (Rp‐cAMPS) can contain biologically active amounts of adenosine.
10. 2 and its mimetic ZK 110.841 are potent inhibitors of receptor‐mediated activation of human neutrophils
11. 2‐receptor agonist. Cardiovasc.
12. 2‐ production and secretion but inhibits migration of activated human neutrophils.
13. i.
14. Characterisation of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils
15. Neutrophil signal transduction and activation of the respiratory burst
16. A stochastic model for leukocyte random motility and chemotaxis based on receptor binding fluctuation.
17. Competitive cAMP antagonists for cAMP‐receptor proteins
18. Chemotaxis and chemokinesis: confusion about definitions
19. Inhibition of the FMLP‐induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series.
20. Vimentin is transiently co‐localised with and phosphorylated by cyclic GMP‐dependent protein kinase in formyl‐peptide‐stimulated neutrophils